BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24709336)

  • 1. Effect of the renin inhibitor aliskiren against retinal ischemia-reperfusion injury.
    Tenkumo K; Hirooka K; Sherajee SJ; Nakamura T; Itano T; Nitta E; Fujita T; Nishiyama A; Shiraga F
    Exp Eye Res; 2014 May; 122():110-8. PubMed ID: 24709336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels.
    Fujita T; Hirooka K; Nakamura T; Itano T; Nishiyama A; Nagai Y; Shiraga F
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4099-110. PubMed ID: 22661470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.
    Batenburg WW; Verma A; Wang Y; Zhu P; van den Heuvel M; van Veghel R; Danser AH; Li Q
    PLoS One; 2014; 9(6):e100954. PubMed ID: 24968134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
    Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aliskiren - a promising strategy for ovarian ischemia/reperfusion injury protection in rats via RAAS.
    Bayir Y; Cadirci E; Polat B; Kilic Baygutalp N; Albayrak A; Karakus E; Un H; Keles MS; Kocak Ozgeris FB; Toktay E; Karaca M; Halici Z
    Gynecol Endocrinol; 2016 Aug; 32(8):675-683. PubMed ID: 26939623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction.
    Verdecchia P; Angeli F; Mazzotta G; Gentile G; Reboldi G
    Vasc Health Risk Manag; 2008; 4(5):971-81. PubMed ID: 19183745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the aldosterone/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injury.
    Liu Y; Hirooka K; Nishiyama A; Lei B; Nakamura T; Itano T; Fujita T; Zhang J; Shiraga F
    Exp Eye Res; 2012 Mar; 96(1):116-23. PubMed ID: 22200488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats.
    Zhang XY; Xiao YQ; Zhang Y; Ye W
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3912-21. PubMed ID: 23557740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats.
    Feldman DL; Jin L; Xuan H; Contrepas A; Zhou Y; Webb RL; Mueller DN; Feldt S; Cumin F; Maniara W; Persohn E; Schuetz H; Jan Danser AH; Nguyen G
    Hypertension; 2008 Jul; 52(1):130-6. PubMed ID: 18490518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.
    Sakoda M; Ichihara A; Kurauchi-Mito A; Narita T; Kinouchi K; Murohashi-Bokuda K; Saleem MA; Nishiyama A; Suzuki F; Itoh H
    Am J Hypertens; 2010 May; 23(5):575-80. PubMed ID: 20075844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes.
    Schmerbach K; Pfab T; Zhao Y; Culman J; Mueller S; Villringer A; Muller DN; Hocher B; Unger T; Thoene-Reineke C
    PLoS One; 2010 Nov; 5(11):e15052. PubMed ID: 21124781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren.
    Schefe JH; Neumann C; Goebel M; Danser J; Kirsch S; Gust R; Kintscher U; Unger T; Funke-Kaiser H
    J Hypertens; 2008 Sep; 26(9):1787-94. PubMed ID: 18698213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotective effect of aliskiren on renal ischemia/reperfusion injury in rats: electron microscopy and molecular study.
    Ziypak T; Halici Z; Alkan E; Akpinar E; Polat B; Adanur S; Cadirci E; Ferah I; Bayir Y; Karakus E; Mercantepe T
    Ren Fail; 2015 Mar; 37(2):343-54. PubMed ID: 25524622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins modulate heat shock protein expression and enhance retinal ganglion cell survival after transient retinal ischemia/reperfusion in vivo.
    Schmeer C; Gámez A; Tausch S; Witte OW; Isenmann S
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4971-81. PubMed ID: 18566458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
    Yoshida S; Ishizawa K; Ayuzawa N; Ueda K; Takeuchi M; Kawarazaki W; Fujita T; Nagase M
    Clin Exp Nephrol; 2014 Aug; 18(4):593-9. PubMed ID: 24154707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells.
    Batenburg WW; de Bruin RJ; van Gool JM; Müller DN; Bader M; Nguyen G; Danser AH
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1151-7. PubMed ID: 18388329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deterioration of kidney function by the (pro)renin receptor blocker handle region peptide in aliskiren-treated diabetic transgenic (mRen2)27 rats.
    te Riet L; van den Heuvel M; Peutz-Kootstra CJ; van Esch JH; van Veghel R; Garrelds IM; Musterd-Bhaggoe U; Bouhuizen AM; Leijten FP; Danser AH; Batenburg WW
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1179-89. PubMed ID: 24694588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation.
    Satofuka S; Ichihara A; Nagai N; Noda K; Ozawa Y; Fukamizu A; Tsubota K; Itoh H; Oike Y; Ishida S
    Diabetes; 2009 Jul; 58(7):1625-33. PubMed ID: 19389828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.
    Koid SS; Ziogas J; Campbell DJ
    Hypertension; 2014 Apr; 63(4):768-73. PubMed ID: 24420538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p90 ribosomal S6 kinase regulates activity of the renin-angiotensin system: a pathogenic mechanism for ischemia-reperfusion injury.
    Shi X; Yan C; Nadtochiy SM; Abe J; Brookes PS; Berk BC
    J Mol Cell Cardiol; 2011 Aug; 51(2):272-5. PubMed ID: 21609719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.